 |
PDBsum entry 4xnj
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transport protein
|
PDB id
|
|
|
|
4xnj
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Acta Crystallogr D Biol Crystallogr
71:1238-1256
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
In meso in situ serial X-ray crystallography of soluble and membrane proteins.
|
|
C.Y.Huang,
V.Olieric,
P.Ma,
E.Panepucci,
K.Diederichs,
M.Wang,
M.Caffrey.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The lipid cubic phase (LCP) continues to grow in popularity as a medium in which
to generate crystals of membrane (and soluble) proteins for high-resolution
X-ray crystallographic structure determination. To date, the PDB includes 227
records attributed to the LCP or in meso method. Among the listings are some of
the highest profile membrane proteins, including the β2-adrenoreceptor-Gs
protein complex that figured in the award of the 2012 Nobel Prize in Chemistry
to Lefkowitz and Kobilka. The most successful in meso protocol to date uses
glass sandwich crystallization plates. Despite their many advantages, glass
plates are challenging to harvest crystals from. However, performing in situ
X-ray diffraction measurements with these plates is not practical. Here, an
alternative approach is described that provides many of the advantages of glass
plates and is compatible with high-throughput in situ measurements. The novel in
meso in situ serial crystallography (IMISX) method introduced here has been
demonstrated with AlgE and PepT (alginate and peptide transporters,
respectively) as model integral membrane proteins and with lysozyme as a test
soluble protein. Structures were solved by molecular replacement and by
experimental phasing using bromine SAD and native sulfur SAD methods to
resolutions ranging from 1.8 to 2.8 Å using single-digit microgram quantities
of protein. That sulfur SAD phasing worked is testament to the exceptional
quality of the IMISX diffraction data. The IMISX method is compatible with
readily available, inexpensive materials and equipment, is simple to implement
and is compatible with high-throughput in situ serial data collection at
macromolecular crystallography synchrotron beamlines worldwide. Because of its
simplicity and effectiveness, the IMISX approach is likely to supplant existing
in meso crystallization protocols. It should prove particularly attractive in
the area of ligand screening for drug discovery and development.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |